findmyKOL
Clinical trialNCT07069933Not, yet, recruitingPhase 2Interventional

Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?

SponsorMansoura UniversityEnrollment50Acute Myeloid Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Moetaza Mahmoud Hassab Soliman

    Associate professor of Clinical Pharmacy, Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University

    Study Director
  • Mohamed el-Husseiny shams

    Professor Department of Clinical pharmacy and Pharmacy practice, Faculty of Pharmacy, Mansoura University

    Principal Investigator
  • Noha Osama Mansour Mansour

    Lecturer of Clinical Pharmacy, Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University

    Study Director
  • Sara Mohamed Ali Atwa

    Lecturer of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Mansoura University

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Egypt
  • Clinical Oncology and Nuclear Medicine of Mansoura University Hospital, Mansoura,

    Al Mansurah, Egypt

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2025
Primary completion
31 Jul 2025
Completion
31 Dec 2025
Last update posted
17 Jul 2025
Registered enrollment
50
Registry id
NCT07069933

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.